As Policymakers Debate Medicare-for-All, Analysis Finds the Medicare Advantage, Individual and Group Health Insurance Markets Appear to Be Profitable, Especially Medicare Advantage August 5, 2019 News Release Three key private health insurance markets — Medicare Advantage, the individual market and the fully-insured group market — appear to be financially healthy and attractive to insurers, according to a new KFF analysis. The private Medicare Advantage market generates significantly larger gross margins per person than the individual market or…
Financial Performance of Medicare Advantage, Individual, and Group Health Insurance Markets August 5, 2019 Issue Brief Three key private health insurance markets — Medicare Advantage, the individual market and the fully-insured group market — appear to be financially healthy and attractive to insurers. The private Medicare Advantage market generates significantly larger gross margins per person than the individual market or fully-insured market. The future of these markets has become a focus for policymakers amid the debate over Medicare for All.
What Steps Are Washington Policymakers Pursuing to Control Medicare Prescription Drug Spending? August 1, 2019 News Release As policymakers in Washington discuss ways to curb the rising cost of prescription drugs, KFF has released a summary and analysis of proposals and recently finalized initiatives that affect Medicare prescription drug spending. Medicare, the federal health program that covers more than 60 million seniors and younger people with disabilities,…
The Democratic Debates Suffer from a Nasty Case of Plan-itis August 1, 2019 Perspective In The Washington Post op-ed “The Democratic Debates Suffer from a Nasty Case of Plan-itis,” Drew Altman says the primary debates are not serving voters well by focusing on details of candidates’ health care plans rather than the fundamental differences between them.
KFF Health Tracking Poll – July 2019: The Future of the ACA and Possible Changes to the Current System, Preview of Priorities Heading Into 2nd Democratic Debate July 30, 2019 Poll Finding This month’s KFF Health Tracking Poll explores public opinion towards a government-administered public option, and finds that attitudes can change after hearing common arguments. The poll also examines the public’s views toward Medicare-for-all and the Affordable Care Act, as well as the top issues for Democrats ahead of the second round of presidential debates.
What’s The Role of Private Health Insurance Today and Under Medicare-for-all and Other Public Option Proposals? July 30, 2019 Issue Brief This brief examines the role private insurers play in providing health coverage for Americans today in employer plans and the individual market, as well as in Medicare and Medicaid, and how that would likely change under Medicare-for-all and other proposals.
Poll: Strong Initial Support for a Public Option, But Arguments Can Significantly Shift Views July 30, 2019 News Release Health Care Remains a Top Issue for Democrats Heading into Next Debates; At This Stage, More Want to Hear About Candidates’ Difference than Contrasts with President Trump The 2020 presidential election may be shaping up to be another election cycle focused on health care, with Democratic candidates offering competing proposals…
As the Ebola outbreak in the DRC continues, new KFF explainer examines the status of the response and the limited U.S. role to date July 29, 2019 News Release The ongoing Ebola outbreak in the Democratic Republic of Congo (DRC), recently declared a “public health emergency of international concern” by the WHO Director-General, is now second only to the West Africa outbreak of 2014-2015 in terms of number of cases and deaths. A new KFF explainer reviews the history…
A Small Group of Patients Account for a Whole Lot of Spending July 29, 2019 Perspective You have heard about the 5% of the population responsible for 50% of spending. Meet the 1.3%–persistent high spenders with very complex medical needs responsible for 20%. Drew Altman discusses this and possible ways to help them, read the Axios column.
Explainer Video Breaks Down Prescription Drug Rebates and Why They Matter in the Debate About Prescription Drug Costs July 26, 2019 News Release A new KFF animation explains how rebates for prescription drugs work, including how they are determined, who benefits from them, how they affect spending by insurers and consumers and the role of pharmacy benefit managers in the process. The Trump Administration had proposed banning such rebates in Medicare Part D,…